Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Magnesium recalled?

Yes — there is an active recall. 21 ongoing FDA recalls mention Magnesium (165 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Magnesium. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Magnesium recalls on record

none so far in 2026; 165 on record, newest first
Class III · Low risk

Epsom Salt

Failed Impurities/Degradation Specifications: Level of iron exceeds the limit set by the USP monograph for it (USP limit is NMT 0.5 ug/g (ppm)).

Terminated Impurity / degradation PQ Corporation D-0564-2016
Class II · Moderate risk

Calm Me Vitamin Cocktail

Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

Terminated Sterility / contamination JD & SN Inc., dba Moses Lake Professional Pharmacy D-0060-2016
Class II · Moderate risk

NEXIUM¿ (esomeprazole magnesium)

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.

Terminated Particulate / foreign matter AstraZeneca Pharmaceuticals LP NDC 00186-5020-31 D-1141-2015
Class II · Moderate risk

Magnesium Chloride 200 mg/ml

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1564-2015
Class I · High risk

Magnesium Sulfate in 5% Dextrose Injection

Labeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9% in sodium chloride injection.

Terminated Labeling / mix-up Hospira Inc. NDC 0409-6727-23 D-1076-2015
Class II · Moderate risk

Magnesium Stearate pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-771-2015
Class II · Moderate risk

Esomeprazole Magnesium Trihydrate active pharmaceutical…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-651-2015
Class II · Moderate risk

EDTA Dipotassium Magnesium Salt Dihydrate active pharmaceutical…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-647-2015
Class I · High risk

Magnesium Chloride 20%

Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.

Terminated Sterility / contamination Pharmacy Creations D-0307-2015
Class II · Moderate risk

Magnesium Sulfate

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-429-2014
Class II · Moderate risk

Magnesium Chl 200 mg/mL PF

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Terminated Sterility / contamination Medaus, Inc. D-1053-2013
Class II · Moderate risk

Magnesium Sulfate Hepta 50% PF

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.

Terminated Sterility / contamination Wellness Pharmacy, Inc. D-1031-2013